Drug Development
AI-native therapeutic design, from target to validated lead. Propose, score and de-risk candidate molecules with the same cited, auditable rigor that Quill brings to constructs.
Products
Telesphorus builds AI-native design intelligence for biology: tools that propose and validate, not just draw. Quill is live today; two more programs are on the way.
Describe a construct in plain English. Quill plans the build, fetches real biological data, designs and validates it, screens it for biosecurity, and returns synthesis-ready output with a GO / CONDITIONAL / NO-GO verdict.
On the roadmap
Same principles: AI that proposes and validates, every decision cited, depth in a niche over breadth. Both are early-stage and not yet available, and can't be requested or inquired about right now. The free pilot is for Quill only.
AI-native therapeutic design, from target to validated lead. Propose, score and de-risk candidate molecules with the same cited, auditable rigor that Quill brings to constructs.
Neuropharmacogenomic screening for the brain. It models CNS drug exposure and response so the right therapy reaches the right patient. A vertical bet: depth in neuro beats breadth.
AI explains and orchestrates; deterministic engines are the source of truth. Every number traces to an engine output or a citation.
A first-class biosecurity gate on every design and every generated candidate. Never silently skipped, never auto-overridden.
Outputs open directly in the tools you already use. We attack lock-in and opaque pricing, so we won't become it.
Free pilot · open
Work directly with the founder and put Quill, our live product, to work on your bench, at no cost. (Drug Development and CNS Screening are still in development and not yet open.)